Quest Diagnostics 2012 Annual Report Download - page 9

6
• immunogenetics and human leukocyte antigens (solid organ and bone marrow transplantation, eligibility for
vaccines, selection of pharmacotherapeutic agents and immunotherapy);
• immunology (the study of the immune system, including antibodies, cytokines, immune system cells and their
effect, receptor systems and autoimmune diseases);
• microbiology and infectious diseases (the study of microscopic forms of life, including parasites, bacteria, viruses,
fungi and other infectious agents);
• oncology (the study of abnormal cell growth, including benign tumors and cancer);
• serology (a science dealing with body fluids and their analysis, including antibodies, proteins and other
characteristics); and
• toxicology (the study of chemicals and drugs and their adverse effects on the body).
We also offer gene-based testing services for the predisposition, diagnosis, treatment and monitoring of cancers. We
provide integrated, comprehensive diagnostic information services that include both anatomic pathology and clinical pathology
testing, enabling our pathologists to offer patients and physicians a complete analysis.
We provide our services through our nationwide network of major laboratories, anatomic pathology laboratories and
rapid response laboratories. Rapid response laboratories are smaller facilities where we can quickly perform an abbreviated
menu of routine tests for customers that require rapid turnaround times. We conduct complex and specialized testing, including
molecular diagnostics, in our world renowned Quest Diagnostics Nichols Institute laboratory facilities and in other facilities,
including Focus Diagnostics and Athena Diagnostics. We operate 24 hours a day, 365 days a year. We also provide routine
testing services, and inpatient anatomic pathology and medical director services, at hospital laboratories.
Most of our services are provided under the Quest Diagnostics brand, but we also provide services under the
AmeriPath,® Dermpath Diagnostics,® Focus Diagnostics® and Athena Diagnostics® brands. Focus Diagnostics® is a leading
provider of infectious disease diagnostic information services and has established a reputation for being first to introduce new
tests to the market, including diagnostic tests for Lyme disease, West Nile Virus, SARS and H1N1. Through Athena
Diagnostics® we have the leading position in the growing neurology diagnostics market. We have a leading position in
advanced cardiovascular diagnostic information services, including our Berkeley HeartLab offering. We have a strong history
of leadership and innovation in cancer diagnostics, including introduction of the Leumeta® family of tests for leukemia and
lymphoma.
International.
We provide diagnostic information services in several markets outside the United States. We have laboratory facilities
in Gurgaon, India; Heston, England; Mexico City, Mexico; and San Juan, Puerto Rico. These laboratories support the provision
of diagnostic information services in their local markets, and also may support our clinical trials business. We have an office in
Ireland that supports our activities in that country. We see opportunities to bring our experience and expertise in diagnostic
information services to markets outside the United States, including by leveraging existing facilities to serve new markets.
Connectivity.
We offer connectivity solutions that provide more convenient ordering and reporting of diagnostic information
services, greater convenience in electronically prescribing medication and better access to information. We believe that our
connectivity solutions enhance the value we provide, help differentiate us from the competition and result in increased
customer loyalty.
The majority of diagnostic information that we provide is delivered electronically, including by taking advantage of
our Care360® products. These products, including Care360 Labs and Meds, enable physicians electronically to order
diagnostic testing and review test results from our Company and electronically to prescribe medication. Physicians also take
advantage of our Care360 Mobile application that lets them review diagnostic information and order medications using their
smartphones or mobile devices. There is a large national healthcare provider network using Quest Diagnostics' Care360
connectivity products.
We also provide patients with tools to manage their healthcare and medical information. Our automated patient
appointment scheduling enables patients to schedule appointments, including via mobile devices, at times that are convenient
for them while reducing or eliminating their waiting time. We also offer TestMinder,® which sends email reminders to patients
who require frequent testing, and Gazelle,® a secure mobile health platform that allows users to receive and archive their Quest
Diagnostics test results, manage their personal health information, find a Quest Diagnostics location and schedule appointments
directly from their smartphone.